Episodic evolution mediates interspecies transfer of a murine coronavirus by Baric, Ralph S. et al.
JOURNAL OF VIROLOGY,
0022-538X/97/$04.0010
Mar. 1997, p. 1946–1955 Vol. 71, No. 3
Copyright q 1997, American Society for Microbiology
Episodic Evolution Mediates Interspecies Transfer of a
Murine Coronavirus
RALPH S. BARIC,1,2* BOYD YOUNT,1 LISA HENSLEY,1 SHEILA A. PEEL,1 AND WAN CHEN1
Program in Infectious Diseases, Department of Epidemiology, University of North Carolina at Chapel Hill,
Chapel Hill, North Carolina 27599-7400,1 and Department of Microbiology and Immunology,
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 275992
Received 21 May 1996/Accepted 11 November 1996
Molecular mechanisms permitting the establishment and dissemination of a virus within a newly adopted
host species are poorly understood. Mouse hepatitis virus (MHV) strains (MHV-A59, MHV-JHM, and MHV-
A59/MHV-JHM) were passaged in mixed cultures containing progressively increasing concentrations of non-
permissive Syrian baby hamster kidney (BHK) cells and decreasing concentrations of permissive murine DBT
cells. From MHV-A59/MHV-JHM mixed infection, variant viruses (MHV-H1 and MHV-H2) which replicated
efficiently in BHK cells were isolated. Under identical treatment conditions, the parental MHV-A59 or MHV-
JHM strains failed to produce infectious virus or transcribe detectable levels of viral RNA or protein. The
MHV-H isolates were polytrophic, replicating efficiently in normally nonpermissive Syrian hamster smooth
muscle (DDT-1), Chinese hamster ovary (CHO), human adenocarcinoma (HRT), primate kidney (Vero), and
murine 17Cl-1 cell lines. Little if any virus replication was detected in feline kidney (CRFK) and porcine
testicular (ST) cell lines. The variant virus, MHV-H2, transcribed seven mRNAs equivalent in relative abun-
dance and size to those synthesized by the parental virus strains. MHV-H2 was an RNA recombinant virus
containing a crossover site in the S glycoprotein gene. At the molecular level, episodic evolution and positive
Darwinian natural selection were apparent within the MHV-H2 S and HE glycoprotein genes. These findings
differ from the hypothesis that neutral changes are the predominant feature of molecular evolution and argue
that changing ecologies actuate episodic evolution in the MHV spike glycoprotein genes that govern interspe-
cies transfer and spread into alternative hosts.
Zoonotic viruses are potentially rich sources of new emerg-
ing viral diseases in humans and animals, yet the molecular and
genetic mechanisms permitting the establishment and dissem-
ination of such a virus within a newly adopted host are poorly
understood (1, 2, 36, 39). While many suspect that most new
viral diseases of humans arose by cross-species transmission
from animal reservoirs, virology has largely remained outside
the paradigm of the synthetic theory of evolution (34). Conse-
quently, few studies have addressed at the molecular level the
evolutionary mechanisms which contribute to the emergence
and dissemination of new viral diseases in nature. This is un-
fortunate since evolution occurs at about 1 million-fold faster
in RNA viruses than in their eukaryotic host counterparts,
providing unparalleled power in studying fundamental princi-
ples in evolution (26).
Two principal mechanisms of evolution have been proposed
at the molecular level. According to the more widely accepted
neutral or nearly neutral theories (24, 27, 45), the majority of
changes and polymorphisms at the molecular level result from
the random fixation of selectively neutral or very nearly neutral
mutations during continued pressure rather than by positive
Darwinian natural selection. Since the majority of mutations
are thought to be deleterious or lethal, silent substitution rates
exceed replacement substitution rates because they are less
subject to purifying selection. Mutation rates are believed to be
relatively constant per generation, resulting in a near-constant
molecular evolutionary clock, with functionally less important
portions of genes evolving faster than more critical domains
(27, 45). In contrast, the episodic selection theory argues that
molecular evolution is evolving in response to a slowly chang-
ing environment (20, 21). Rates of evolution increase during
periods of environmental flux, negatively impacting progenitor
viral quasispecies and selecting for the subsequent formation
of new viral species (21). As environmental conditions change,
previously deleterious alleles become more fit than the cur-
rently fixed alleles. The population evolves in short bursts by
positive Darwinian selection at the molecular level, followed by
longer periods of time with low levels of nucleotide substitu-
tion. Eldredge and Gould’s theory of punctuated equilibrium
(14), which was first used to explain phenotypic radiation dur-
ing primate evolution, has more recently been used to explain
the evolution and origin of human immunodeficiency virus
(HIV) and simian immunodeficiency virus at the molecular
level (1). Punctuated equilibrium, like Gillespie’s episodic se-
lection theory (20, 21), proposes that well-adapted populations
maintain relatively low evolution rates until environmental
conditions change, resulting in dramatic shifts in natural selec-
tion and accelerating rates of evolution. For uniformity, we will
refer to these theories as episodic evolution.
Mouse hepatitis virus (MHV) and most other coronaviruses
are extremely species and tissue specific in vivo and in vitro
(28). Host range specificity is most likely mediated at entry
since the MHV genomic RNA is infectious in nonpermissive
cell lines (12, 13, 28). Expression of the MHV receptor, a
biliary glycoprotein (Bgp1), converts nonpermissive Syrian
baby hamster kidney (BHK), human, or primate cell lines into
susceptible hosts for virus replication (12, 13). MHV contains
a single-stranded positive-polarity RNA genome of about
32,000 nucleotides (nt) in length. The plasticity of the corona-
virus genome is evidenced by high mutation (;1024) and RNA
recombination (;20%) rates, predicting a significant latent
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capacity to evolve rapidly during periods of environmental flux
(4, 18, 29, 33). In this report, we describe the isolation and
characterization of host range mutants of MHV which repli-
cate efficiently in normally nonpermissive BHK, Chinese ham-
ster ovary (CHO), human, and primate cell lines. Given the
nearly unprecedented transformation in the world’s ecology,
our findings suggest that RNA viruses demonstrating short
generation times, high polymerase error, and high recombina-
tion rates may adapt rapidly by episodic evolution and positive
Darwinian natural selection. The new viral forms surviving the
period of adjustment to a new host may remodel those sites of
virus-host interaction that initially enable broad-host-range in-
terspecies transfer followed by subsequent speciation, dissem-
ination, and emergence as new viral diseases in humans, ani-
mals, and plants.
MATERIALS AND METHODS
Virus strains and cell culture conditions. The MHV strains MHV-A59 and
MHV-JHM were used throughout the course of these studies. Virus stocks were
propagated in 150-cm2 flasks containing DBT cells at 378C, and titers were
determined by plaque assay in DBT cells (4, 18). DBT cells were maintained at
378C in Dulbecco’s modified essential medium (DMEM) containing 6% fetal calf
serum (FCS), 4% newborn calf serum, 5% tryptose phosphate broth (TPB), and
1% gentamicin-kanamycin (GIBCO). BHK cells were kindly provided by Robert
E. Johnston (University of North Carolina) and propagated at 378C in DMEM
containing 10% FCS, 5% TPB, and 1% penicillin-streptomycin (GIBCO).
DDT-1 cells, a Syrian hamster smooth muscle cell line, were propagated at 378C
in minimal essential medium (MEM) containing 10% FCS, 5% TPB, and 1%
penicillin-streptomycin. CHO cells were maintained in MEM containing 10%
FCS, 5% TPB, and 1% gentamicin-kanamycin at 378C. Human adenocarcinoma
(HRT) cells were kindly provided by Brenda Hogue (Baylor College of Medi-
cine) and maintained at 378C in DMEM-H (D-glucose; 4,500 ng/liter) containing
7% FBS, 10% TPB, and 1% penicillin-streptomycin. Porcine testicular (ST) cells
were also provided by Brenda Hogue and maintained at 378C in Eagle’s MEM
containing 10% FBS, 13 nonessential amino acids, and 1% penicillin-strepto-
mycin. Feline kidney (CRFK) cells were kindly provided by Julie Levy, North
Carolina State University, and were maintained at 378C in DMEM-H containing
8% FCS and 1% gentamicin-kanamycin. African green monkey kidney (Vero)
cells were maintained at 378C in Eagle’s MEM containing 10% FCS and 1%
penicillin-streptomycin.
Selection for host range mutants. To select for host range mutants, MHV-
A59, MHV-JHM, or an equal mix of both MHV-A59 and MHV-JHM was
inoculated onto cultures containing 90% DBT and 10% BHK cells. Supernatants
were harvested between 18 and 24 h postinfection, and the progeny virions were
inoculated onto identical cultures of mixed cells. After ;5 serial passages under
similar conditions, the concentrations of cells were adjusted in 10% increments
until cultures eventually contained 10% DBT and 90% BHK cells. After 89 serial
undiluted passages, viruses were isolated from the mixed MHV-A59/MHV-
JHM-infected cultures, which replicated and produced syncytia in BHK cells.
Since these variants could not be efficiently passaged in BHK cells, persistently
infected BHK cells were established with the mixed MHV-A59/MHV-JHM
passage 89 virus stocks. Persistently infected cultures were passaged at 3- to 5-day
intervals for an additional 3 months. Virus variants (MHV-H1, MHV-H2, etc.)
which replicated to high titer, produced syncytia within 36 to 48 h, and could be
continuously passaged in BHK cells were subsequently isolated. Virus variants
were plaque purified in BHK cells, individual plaques were purified again by
plaque assay in DBT cells, and virus stocks were propagated in BHK cells for
further use.
Virus growth curves and RNA synthesis. Cultures of BHK, DDT-1, CHO,
17Cl-1, HRT, Vero, CRFK, and ST cells in 60-mm2 dishes were infected with
MHV-A59, MHV-JHM, MHV-H1, or MHV-H2 at a multiplicity of infection
(MOI) of 10. After 1 h at room temperature, the plates were washed twice with
4 ml of phosphate-buffered saline, overlaid with complete medium, and main-
tained at 378C. Virus samples were harvested from supernatant culture fluids at
the designated times, and virus growth curves were determined by plaque assay
in DBT cells (4, 18). Intracellular RNA was also harvested from duplicate
60-mm2 dishes, using RNA STAT-60 reagents as previously described (9).
To quantify levels of viral RNA, equivalent amounts of intracellular RNA (4.5
and 0.5 mg) were bound to nitrocellulose filters by using a Bio-Rad slot blot
apparatus. The blots were hybridized with a radiolabeled MHV-H2 cDNA probe
which spans nt 844 to 1415 in the N (nucleocapsid) gene (47). Briefly, the
MHV-H2 N gene was cloned by reverse transcriptase PCR. cDNA was tran-
scribed by using random primers and 200 U of Moloney murine leukemia virus
reverse transcriptase (BRL) in a 20-ml reaction mixture containing 1 mg of
MHV-H2 intracellular RNA, 4 ml of 53 first-strand reaction buffer (BRL), 2 ml
of 0.1 M dithiothreitol (BRL), 1 ml of 10 mM deoxynucleoside triphosphate
(Pharmacia), and 1 U of RNase inhibitor (Promega) for 1 h at 378C. The cDNA
products were precipitated in ethanol and resuspended in 20 ml of deionized
distilled H2O. Forward (59-CCAGTGCAGCAGTGTTT-39; nt 844 to 860) and
reverse-sense (59-ACTTTCTCGCGAGGGGTTAC-39; nt 1396 to 1415) oligo-
nucleotide primer pairs were synthesized from highly conserved domains within
the MHV N gene (47) and used for PCR amplification of a 571-nt MHV-H2 N
gene DNA fragment. The DNA was inserted into pGEM-2, isolated after re-
striction digestion, and radiolabeled by using random primers and [32P]dCTP.
Blots were probed at 428C in 50% formamide buffer containing 10 mM sodium
phosphate buffer (pH 7.0), 53 Denhardt’s solution (13 Denhardt’s solution is
0.2 mg of Ficoll, 0.2 mg of polyvinylpyrrolidine, and 0.2 mg of bovine serum
albumin per ml), and 100 mg of salmon sperm DNA per ml. The blots were
washed twice at 658C in 23 SSC (13 SSC is 0.15 M NaCl and 0.015 M sodium
citrate) containing 0.2% sodium dodecyl sulfate (SDS), three times in 0.23 SSC
containing 0.2% SDS, and twice in 0.23 SSC containing 0.1% SDS. The blots
were dried and exposed to XAR-5 film with an intensifying screen and scanned
by the AMBIS radioanalytic imaging system (RIS) (AMBIS, San Diego, Calif.).
Size analysis of MHV-H2 mRNAs. Viral RNAs were radiolabeled in 17Cl-1 or
BHK cells. Cultures were seeded at densities of 3 3 105 to 5 3 105 cells per
35-mm2 dish in 90% phosphate-free MEM containing 5% FCS and 3% newborn
calf serum for 12 h. After infection with MHV-A59, MHV-JHM, MHV-H1, or
MHV-H2, cultures were overlaid in 99% phosphate-free DMEM (pH 6.8) and
incubated at 378C. At the indicated times, the cultures were treated with
actinomycin D (10 mg/ml) for 1 h and then radiolabeled with 300 mCi of
[32P]orthophosphate per ml for 1 h. The viral mRNAs were extracted and
analyzed in 0.8% agarose gels containing Tris-borate-EDTA.
Cloning and sequencing the MHV-H2 genome. Intracellular RNA was isolated
from MHV-H2-infected BHK cells at 24 h postinfection, using RNA STAT-60
reagents (total RNA/mRNA isolation reagent) as instructed by the manufacturer
(Tel-Test “B”, Inc.). To clone the MHV-H2 genome, several reverse transcrip-
tase PCRs were performed with primer pairs located between open reading
frame (ORF) 1b (nt 8015) and the HE gene (nt 891), nt 696 to 2080 in the HE
gene, nt 1991 in HE to nt 669 in S, nt 629 to 2119 in S, nt 2066 to 4060 in S, nt
4041 in S to nt 536 in ORF 5B, nt 324 in ORF 5B to nt 476 in N, and nt 780 in
M to nt 1415 in N (3, 31, 32, 47, 50, 54, 65, 66). Individual PCR products were
isolated from agarose gels by using Qiagen reagents (Qiagen, Inc., Chatsworth,
Calif.) and subcloned into TA cloning vectors (Promega). Positive clones were
sequenced by the dideoxy method.
Statistical analysis and mutation rate calculations. Rates of mutation fixation
per year as well as nonsynonymous and synonymous mutation rates per year were
calculated as described previously (24, 26). All statistical tests were performed
with EPI 6 software (Centers for Disease Control and Prevention, Atlanta, Ga.;
World Health Organization, Geneva, Switzerland). Two-by-two contingency
tests were used to compare the frequency of nucleotide changes relative to the
size of a particular gene. Chi square or Fisher exact tests were used to determine
if significantly different mutation rates per year were detected within different
MHV-H2 genes or clusters of genes. Using the same approach, chi square or
Fisher exact tests were used to determine if significantly different synonymous
and nonsynonymous mutation fixation rates occurred within different portions of
the MHV-H2 genome.
RESULTS
Isolation of MHV variants that bridge the species barrier.
Because changing environmental niches appeared to favor the
emergence and interspecies transfer of zoonotic pathogens in
natural settings (36, 39), we passaged MHV in progressively
decreasing concentrations of murine DBT cells (permissive)
and progressively increasing concentrations of BHK cells (non-
permissive). BHK cells were chosen since MHV fails to enter
or replicate in these nonpermissive cells (9, 12, 13), yet MHV-
JHM causes receptor independent fusion between murine and
BHK cell lines in vitro (19). This may enhance the opportunity
for virus evolution and adaptation to hamster cell lines. MHV-
A59, MHV-JHM, or an equal mix of both viruses was serially
passaged in separate cultures containing 90% DBT and 10%
BHK cells. Every ;5 passages, the concentrations of DBT and
BHK cells were altered in 10% increments; i.e., virus from
passage 5 was inoculated onto cultures containing 80% DBT
and 20% BHK cells. Between passages 30 and 75, virus prog-
eny were inoculated onto 70% BHK–30% DBT cell mixtures
because inadequate virus replication was detected in higher
ratios of BHK cells. After passage 75, the concentrations of
cells was slowly adjusted to 90% BHK and 10% DBT cells over
the next 14 passages. By passage 89, only the mixed MHV-
A59/MHV-JHM inoculum caused significant syncytia (;50%)
and cell death in 100% of BHK cells (Fig. 1). In contrast, only
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minor amounts of cytopathic effect and viral RNA were de-
tected in MHV-A59- or MHV-JHM-infected BHK cells (data
not shown).
Since virus evolution is enhanced during persistent infection
(9) and because the progeny from the passage 89 MHV-A59/
MHV-JHM mixed infection were rapidly lost with serial pas-
sage in 100% of BHK cells, we continuously cultured the per-
sistently infected BHK cell survivors. Low levels of infectious
virus were detected for 3 months, at which time progeny virions
were serially passaged 15 times in 100% BHK cells, demon-
strating that MHV host range mutants had evolved (Fig. 1).
Viruses from passages 6 (MHV-H1) and 15 (MHV-H2) were
plaque purified in BHK cells, and stocks were propagated for
use in subsequent experiments. The MHV-H variants were
small-plaque mutants in both BHK and DBT cells. In DBT
cells, the MHV-H2 variant produced plaques significantly
smaller, 0.07 6 0.02 mm, than the 0.24 6 0.04-mm plaques for
MHV-A59 or MHV-JHM (P , 0.001). Interestingly, serial
passage of MHV-A59 or MHV-JHM singly infected mixed
cultures did not result in the emergence of isolates that bridged
the species barrier.
Virus growth curves in murine and Syrian hamster cell
lines. To characterize the host range phenotype of the MHV-H
variants, cultures of 17Cl-1 (murine) and BHK cells were in-
fected with MHV-A59, MHV-JHM, MHV-H1, or MHV-H2 at
an MOI of 10 for 1 h at room temperature. The cultures were
overlaid with medium, and virus samples were isolated at dif-
ferent times postinfection (Fig. 2). In 17Cl-1 cells, MHV-A59
and MHV-JHM replicated to titers approaching 108 and 107,
respectively. Under identical conditions of treatment,
MHV-H1 and MHV-H2 replication was less efficient, with
titers approaching ;4 3 106. Both parental viruses, as well as
the MHV-H variants, produced significant syncytia in 17Cl-1
cells within ;16 h postinfection. In agreement with previous
studies, no MHV-A59 or MHV-JHM replication was detected
in BHK cells (9, 13, 28). Under identical treatment conditions,
however, both hamster-derived variants produced extensive
syncytia and replicated to titers approaching 108 within 36 to
48 h postinfection. Using a polyclonal antiserum against
MHV-3 and fluorescent antibody staining techniques, we de-
termined that MHV-specific antigens were clearly present in
the MHV-H2-infected BHK cultures but not in those infected
with MHV-A59 or MHV-JHM (data not shown). These data
suggested that MHV-H2 was antigenically similar to MHV-
A59 and MHV-JHM.
The MHV-H2 isolate was also more virulent in murine DBT
and 17Cl-1 cells, resulting in .99.998% cell mortality in 30 h,
compared with only ;96.0% cell mortality with MHV-A59 or
MHV-JHM. MHV-H2 was also extremely cytolytic and de-
stroyed over .99.998% of the BHK cell monolayer within 4
days postinfection. Under identical conditions, no BHK cell
death was evident in MHV-A59- or MHV-JHM-infected cul-
tures.
Viral RNA synthesis in 17Cl-1 and BHK cells. To provide
additional evidence that the MHV-H2 variant virus replicated
efficiently in 17Cl-1 and BHK cells, cultures were infected and
intracellular RNA isolated at different times postinfection.
Equivalent amounts of intracellular RNA were bound to ni-
trocellulose filters and probed with a PCR fragment spanning
nt 844 to 1415 in the MHV-H2 N gene. The MHV-H2 probe
detected MHV-A59 and MHV-H2 RNAs in 17Cl-1 cells, dem-
onstrating that the MHV-H2 variant was closely related to the
parental MHV strains (data not shown). The blots were
scanned by AMBIS RIS, and levels of viral RNA were quan-
tified and graphed (Fig. 3). Both parental viruses and
MHV-H2 transcribed significant quantities of viral RNAs fol-
lowing infection of 17Cl-1 cells. Interestingly, while MHV-H2
replicated to lower titers than either of the parental viruses in
17Cl-1 cells, equivalent amounts of viral RNA were detected
with this assay. Consistent with the ability to make infectious
virus, only MHV-H2 synthesized significant quantities of viral
FIG. 1. Selection scheme for host range mutants of MHV in vitro.
FIG. 2. Virus growth in murine and Syrian hamster cell lines. Cultures of
17Cl-1 and BHK cell lines containing 23 106 cells were infected with MHV-A59,
MHV-JHM, MHV-H1, or MHV-H2 at an MOI of 10 for 1 h at room temper-
ature. The inoculum was removed, the monolayers were washed twice, and
samples were taken at the indicated times for plaque assay in DBT cells.
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RNA in BHK cells (Fig. 3). Similar findings were evident with
MHV-H1 (data not shown).
Viral transcription in 17Cl-1 and BHK cells. To compare
the quantities and sizes of the parental and hamster-adapted
viral mRNAs, cultures of 17Cl-1 and BHK cells were infected
with MHV-H2, MHV-H1, MHV-A59, or MHV-JHM and ra-
diolabeled with [32P]orthophosphate from 6 to 7 and 17 to 18 h
postinfection, respectively. The different labeling periods re-
flected the delay in MHV-H2 replication seen in BHK cells
compared with its replication in murine cell lines. After radio-
labeling, intracellular RNA was isolated and separated on
0.8% agarose gels. Seven viral mRNAs were synthesized by
MHV-H2 and the parental viruses in 17Cl-1 cells, although the
sizes of MHV-H2 mRNAs 2 and 3 were more like those of
MHV-JHM (Fig. 4A). Similar findings were noted with MHV-
H1 (data not shown). Increased rates of transcription were also
noted with MHV-H2 in 17Cl-1 cells compared to the parental
controls. As expected, only the MHV-H variants transcribed
detectable levels of viral mRNA in BHK cells (Fig. 4B). These
results suggest that the MHV-H2 and MHV-H1 isolates are
more homologous to MHV-JHM than MHV-A59, especially
in the S and HE glycoprotein genes.
Host range specificity of the MHV-H2 isolate. Genetic al-
terations in the MHV-H variant viruses may have accorded a
specific capacity to infect hamster cells or bestowed a broader
host range specificity. To address this question, we analyzed
the replication efficiencies of these viruses in various host spe-
cies in vitro.
Cultures of cells were infected with MHV-A59 or MHV-H2,
and virus titers and intracellular RNA were examined at dif-
ferent times postinfection. Not surprisingly, MHV-H2 repli-
cated most efficiently in cell lines derived from Mesocricetus
auratus (Syrian) hamsters (DDT-1) and Cricetulus griseus (Chi-
nese) hamsters (CHO). In DDT-1 cells, MHV-H2 produced
significant syncytia by 30 h and reached titers approaching 108
PFU/ml within ;36 to 40 h postinfection. In CHO cells, the
MHV-H2 replication cycle was completed within ;16 h, with
titers approaching 107 PFU/ml (Fig. 5A). Significant amounts
of syncytia were evident within;8 to 12 h. The distinct rates of
MHV-H2 replication and syncytium formation noted in differ-
ent hamster and murine cell lines are intriguing and may re-
flect different rates of virus entry and uncoating. Consistent
with the ability of MHV-H2 to produce infectious virus in both
cell lines, significant quantities of viral RNA were also synthe-
sized throughout infection (Fig. 5B). Under identical condi-
tions, no evidence of parental virus replication or RNA syn-
thesis was noted in either cell line.
Significant amounts of MHV-H2 replication were also evi-
dent in primate (Vero) and human (HRT) cell lines, with virus
titers approaching ;106 PFU/ml within ;36 h postinfection
(Fig. 6 and 7). Increased levels of MHV-H2 RNA synthesis
were also evident in these cell lines (Fig. 6 and 7). Under
identical treatment conditions, no parental MHV-A59 or
MHV-JHM replication was apparent. These results indicated
that genetic changes in the MHV-H2 genome have conferred
a broad host range specificity. Since little virus replication and
RNA synthesis were observed in ST (porcine) cells and no
replication was evident in CRFK (feline) cells, specific host
factors were still required to initiate a productive MHV-H2
infection (Fig. 6 and 7).
MHV-H2 genomic organization. To elucidate the molecular
basis for MHV interspecies spread, we sequenced the 39-most
;10 kb of the MHV-H2 genome (Fig. 8 and Table 1).
MHV-H2 was an RNA recombinant virus containing a 59 end
derived from MHV-JHM and a 39 end derived from MHV-
A59. The crossover site in MHV-H2 resided between nt 3394
and 3417 within the ;4.1-kb S glycoprotein, effectively intro-
ducing nine MHV-A59 amino acid changes into the MHV-
JHM S glycoprotein gene (32, 50). No amino acid changes
were detected in the N gene, SM glycoprotein gene (ORF 5B),
ORF 5A, or ORF 2 genetic domain, demonstrating that these
loci do not encode critical determinants of interspecies spread
(Fig. 8 and Table 1). No alterations were noted within the
FIG. 3. Viral RNA synthesis in murine and Syrian hamster cell lines. Cul-
tures of 17Cl-1 and BHK cell lines containing 2 3 106 cells were infected with
MHV-A59 or MHV-H2 at an MOI of 10 for 1 h at room temperature. Intra-
cellular RNA was isolated from the cells at the designated time points, equiva-
lent amounts were bound to nitrocellulose filters and probed with an MHV-H2
N gene cDNA probe, and total counts per minute was quantified by AMBIS RIS.
FIG. 4. Viral RNA synthesis in murine and hamster cell lines. Cultures of
17Cl-1 or BHK cells were infected with MHV-A59, MHV-JHM, MHV-H1, or
MHV-H2 at an MOI of 10 for 1 h. The cultures were radiolabeled with 300 mCi
of [32P]orthophosphate per ml from 7 to 8 h postinfection in 17Cl-1 cells or 17
to 18 h postinfection in BHK cells. Intracellular RNA isolated and separated on
0.8% agarose gels. (A) 17Cl-1 cells infected with MHV-A59 (lane 1), MHV-H2
(lane 2), or MHV-JHM (lane 3); (B) BHK cells infected with MHV-A59 (lane
1), MHV-H2 (lane 2), or MHV-H1 (lane 3).
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FIG. 5. Virus replication in Syrian and Chinese hamster cell lines. Cultures
of Syrian hamster smooth muscle (DDT-1) or CHO cells were infected with
MHV-A59 or MHV-H2 at an MOI of 10 for 1 h. The inoculum was removed, the
monolayers were washed twice, and samples were taken at the indicated times for
plaque assay in DBT cells. (A) Virus replication in DDT-1 and in CHO cells; (B)
viral RNA synthesis in CHO and DDT-1 cells.
FIG. 6. Virus replication in primate and feline cell lines. Cultures of African
green monkey kidney (Vero) and feline kidney (CRFK) cells were infected with
MHV-A59 or MHV-H2 at an MOI of 10 for 1 h. The inocula were removed, the
monolayers were washed twice, and samples were taken at the indicated times for
plaque assay in DBT cells. (A) Virus replication in Vero and CRFK cells; (B)
virus RNA synthesis in Vero and CRFK cells.
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MHV-H2 intergenic domains. A single C-terminal amino acid
alteration was detected in the MHV-H2 M glycoprotein gene;
this is an unlikely candidate for interspecies spread since it
functions in assembly and release (3, 28). The amino acid 2
mutation in ORF 4 is also an unlikely candidate since it en-
codes a nonstructural protein which has been shown superflu-
ous to productive viral infection (28, 65). Calculated mutation
rates per site per year averaged (3.84 6 2.25) 3 1023 in the
MHV-H2 N, M, ORF 5, ORF 4, and ORF 2 genetic domains.
The majority of amino acid alterations were detected within
the MHV-H2 S and HE glycoprotein genes (Fig. 8). Overall,
mutation rates in the MHV-H2 genome (including changes
from recombination) were increased ;3.0- to 4.0-fold in the S
and HE glycoprotein genes and averaged 16.13 3 1023 and
10.85 3 1023 per site per year, respectively. Using two-by-two
contingency tests, we noted significant increases in the number
of mutations within the MHV-H2 S (x2 5 13.88, P , 0.001)
and HE (x2 5 5.22, P , 0.03) glycoprotein genes compared to
the remaining subgenomic ORFs. In addition to the crossover
site in the S glycoprotein gene, the region of polymorphism (nt
1359 to 1626) was extended by the removal of 12 additional
amino acids (48), resulting in the insertion of an Arg residue.
A 3-nt deletion between nt 2813 and 2815 resulted in the loss
of position 938 proline. An additional eight mutations were
noted in the S glycoprotein; six resulted in amino acid changes
within the S1 domain, including a position 717 Arg-Gln change
that resided within the S1-S2 protease cleavage site (25). Two
additional amino acid changes were noted in S2. Rates of HE
mutation fixation were increased about 2.6-fold compared to
subgenomic ORFs which do not function in entry (P , 0.03).
Interestingly, six of eight mutations resulted in amino acid
changes (Table 1).
Evolutionary mechanisms for MHV-H2 interspecies trans-
fer. Since MHV-H2 was derived from known progenitor strains
over a 200-day period under clearly defined conditions of en-
vironmental flux, this biological model allowed us to elucidate
the molecular evolutionary processes governing virus host
range specificity in vitro. We have demonstrated an increased
rate of evolution in the S and HE glycoprotein genes relative to
evolution rates noted in viral genes that do not function in
entry, suggesting that specific portions of the MHV-H2 ge-
nome may have evolved by episodic evolution. Overall rates of
nonsynonymous mutations were also shown to be increased in
the MHV-H2 attachment genes (HE and S) compared to the
remaining subgenomic ORFs (x2 5 10.65, P , 0.002) (Table
2). Individual increases in both the HE (x2 5 11.71, P, 0.001)
and S (x2 5 4.93, P , 0.03) genes compared to rates in the
remaining subgenomic ORFs were noted (Table 2). Inclusion
of the 12-amino-acid deletion noted in the region of S gene
polymorphism resulted in even greater statistical significance
(x2 5 18.11, P , 0.001) in the nonsynonymous mutation rate.
Importantly, no synonymous mutations were detected within
the MHV-H2 S gene, and only two of eight mutations were
synonymous in HE (Tables 1 and 2). In contrast, viral genes
which did not function in entry demonstrated near genetic
stasis, with synonymous changes predominating (Tables 1 and
2). Since neither lineage effects nor neutral theory could ac-
count for the evolutionary pulse or the increased rate of non-
synonymous mutations detected within the MHV-H2 HE and
S genes, episodic evolution and positive Darwinian selection at
the molecular level likely modulated interspecies transfer in
vitro (14, 20, 21).
DISCUSSION
Virus interspecies traffic. Animal virus host range specificity
and the evolution of new viral diseases are complex phenom-
ena involving interactions between the virus, the host, and the
environment. Emerging viruses are frequently defined as either
newly recognized viruses or viral pathogens that are rapidly
FIG. 7. Replication in human and porcine cell lines. Cultures of human
adenocarcinoma (HRT) and porcine testicular (ST) cells were infected with
MHV-A59 or MHV-H2 at an MOI of 10 for 1 h. The inoculum was removed, the
monolayers were washed twice, and samples were taken at the indicated times for
plaque assay in DBT cells. (A) Virus replication in HRT and ST cells; (B) virus
RNA synthesis in HRT and ST cells.
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increasing in incidence or expanding in geographic range (1,
36). Recent examples include equine morbillivirus, HIV, han-
tavirus, hemorrhagic fever viruses, arboviruses, and bovine
spongiform encephalopathy, canine distemper, and influenza
viruses (2, 36, 39). While these newly emerging pathogens are
highly heterogeneous in their structures and replication strat-
egies, many are zoonotic pathogens that have bridged the spe-
cies barrier by evolving the capacity to interact with specific
cellular factors which normally function to ablate virus entry,
replication, or transmission in the new host species.
Coronaviridae include a diverse group of highly species spe-
cific avian and mammalian viruses. While human coronavirus
(HCV-229E and HCV-OC43) infections are associated with
about 15 to 30% of the common colds in winter, human and
murine-like neurotropic coronaviruses are also present in
chronic neurological diseases such as multiple sclerosis (7, 42,
55). Newly emerging coronavirus infections include porcine
epidemic diarrhea virus, a close relative of HCV-229E, and
porcine respiratory disease virus, which probably evolved from
transmissible gastroenteritis virus (5, 49).
Among RNA viruses, host range specificity is usually medi-
ated at the level of entry and has been best studied in murine-
adapted strains of picornaviruses and with influenza virus (63).
In the Lansing strain of poliovirus, murine adaptation primar-
ily involved changes in the viral capsid proteins that permitted
entry into the adopted host (41). Rhinovirus host range spec-
ificity has been found to be mediated at entry and during virus
replication (63, 64). Among influenza A viruses, host range
discrimination was polygenic and primarily involved genetic
determinants within the nucleoprotein that affected the repli-
cation of the virus in various hosts (22, 51). Other influenza
virus genes, including the hemagglutinin and polymerase
genes, also encoded important determinants affecting host
range specificity (6, 56, 58). Canine parvovirus type 2 emerged
in 1978 as a variant of feline panleukopenia virus or some
other closely related parvovirus infecting carnivores (46). Host
range expansion was due to a few changes in a region of the
virus capsid where three protein monomers interact (59). As
for picornaviruses, variants of MHV-JHM that replicate effi-
ciently and produce a panencephalitis with accompanying de-
myelination in the primate central nervous system have been
isolated after in vivo passage (43).
In contrast to other models, we have isolated host range
mutants by altering the natural ecosystem in vitro. By estab-
lishing a transmission impediment (10, 26), new viral variants
which replicated more efficiently than either parental strain in
the new host cell environment evolved. Since MHV variant
viruses isolated from persistently infected cultures of DBT
FIG. 8. Organization of the MHV-H2 genome. The organization of the MHV-A59 (open) and MHV-JHM (hatched) genomes are shown in relation to the
organization of the MHV-H2 genome. Individual viral genes are boxed according to their locations in the MHV genome. MHV-H2 is an RNA recombinant virus
containing portions of both MHV-A59 and MHV-JHM with the crossover site residing within the S glycoprotein gene. The region of polymorphism in the MHV-JHM
S glycoprotein gene is extended by the removal of an additional 12 amino acids in the MHV-H2 genome (48). The locations of the amino acid changes in the MHV-H2
S and HE glycoprotein genes are also shown.
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cells do not evolve the capacity to replicate in hamster cell lines
in vitro (9), it seems likely that the MHV-H host range variants
evolved in response to the presence of increasing concentra-
tions of BHK cells. Efficient MHV-H adaptation and replica-
tion, however, were not accomplished until a persistent infec-
tion was established in hamster cell lines. Although the
mechanism is speculative, persistent infection may have se-
lected not only for the emergence of resistant host cells that
expressed little receptor protein but also for the subsequent
coevolution of more virulent virus variants that recognized
alternative receptors for entry (9).
Interestingly, serial passage of singly infected MHV-A59
and MHV-JHM cultures did not result in the emergence of
isolates that replicated efficiently in hamster cell lines. While
these findings do not imply that host range mutants of MHV-
A59 or MHV-JHM cannot evolve under continued selection,
mechanistically, rapid evolution in the MHV-H2 S glycopro-
tein gene was primarily driven by RNA recombination. These
findings suggest that RNA recombination maximizes the rate
at which genetic variability accumulates in viral genes critical
for host range specificity (16, 28). In support of this hypothesis,
type-specific oligonucleotide probes demonstrated that at least
five other MHV-H isolates were recombinant viruses contain-
ing a genome organization like MHV-H2 (data not shown).
The increased MHV-H virulence in vitro may also reflect a
serious consequence of recombination and cross-species trans-
mission of zoonotic viruses in nature, an extremely cytolytic
course of infection in the adopted host (15). For example,
simian immunodeficiency virus infection is extremely cytolytic
in human cell lines yet produces a noncytolytic infection in the
natural host (1).
Our in vitro model likely reflects mechanisms of virus adap-
tation associated with mixed cell populations in vivo; similar
conditions are present in humans following xenotransplanta-
tion. Mystery virus adaptation to the human host may be a
concern in xenotransplant recipients (35). Although specula-
tive, our findings suggest that heavily immunosuppressed xe-
nograph recipients may represent an ideal environment for
rapid zoonotic virus adaptation and dissemination into the
human host.
Mechanisms of MHV interspecies transfer. Selection for
efficient MHV replication in BHK cells resulted in variants
with polytrophic host range phenotypes. In vivo examples of
similar phenomena include influenza virus (H1N1) in swine,
which probably emerged following the 1918 human pandemic,
and the avian-derived 1979–1980 seal influenza virus (H7N7),
which also caused conjunctivitis in humans (23, 52, 53, 62).
While the natural reservoir of equine morbillivirus is unknown,
zoonotic transfer resulted in increased morbidity and mortality
in both equine and human hosts (40). These examples suggest
that interspecies transfer of viruses may evolve by changes
which confer broad host range specificity, followed by adapta-
tion and speciation within a particular host.
MHV-H2 has likely remodeled its normal interactions with
cellular receptors. Although we cannot exclude the possibility
that mutations in the ORF 1a or ORF 1b polymerase gene may
have contributed to MHV-H2 replication, the sequence data
suggest that the HE and S glycoprotein genes represent the
principal genetic determinants mediating interspecies traffic of
coronaviruses. While the MHV HE glycoprotein is not re-
quired for entry (31, 66), the MHV-H2 HE may now function
like the bovine coronavirus HE glycoprotein and recognize
neuramic acid residues on cellular proteins as receptors for
entry (28, 60). Alternatively, the S glycoprotein gene interacts
with the murine Bgp glycoprotein receptor (12, 13, 57, 66).
Since human, rat, and murine Bgps are highly conserved in
nature and vary by 60 to 90% at the amino acid level (30), this
model may reveal whether phylogenetic homologs of the nor-
mal receptor function as natural conduits for interspecies traf-
fic of coronaviruses.
Interspecies transfer and coronavirus evolution. Phyloge-
netic analysis of the group II coronaviruses have predicted two
clades, one containing bovine coronavirus and HCV-OC43 and
the other containing MHV and rat coronaviruses (37, 38, 67).
Comparisons of sequences among the viruses indicate that the
N and M structural proteins are most highly conserved, with
the greatest sequence diversity evident in the S and HE glyco-
protein genes. In the S gene, the greatest heterogeneity is
detected within the S1 domain (31, 32, 37, 38, 48, 67). These
TABLE 1. Locations of synonymous and nonsynonymous
mutations in the MHV-H2 genome
Viral gene Mutation nt position Amino acid
N gene A-T 69 No change
T-A 441 No change
T-C 612 No change
M gene G-A 103 No change
C-T 541 No change
T-C 759 Ile-Thr
ORF 5A G-T 18 Noncoding
ORF 5B No change
ORF 4 G-T 88 Val-Leu
S genea C-T 520 Val-Leu
CTG-GCT 763–765 Leu-Ala
C-A 842 Ala-Val
A-G 1205 Asp-Gly
CGCb Argb
A-C 1849 Asn-His
G-A 2150 Arg-Gln
A-G 2696 Glu-Gly
CCAc 2812–2814 Del Proc
G-T 3448 Asp-Tyr
HE gene T-C 926 Val-Ala
T-G 996 Val-Gly
C-A 1104 Asp-Lys
T-C 1122 No change
T-C 1421 Val-Ala
G-C 1497 No change
G-C 1596 Leu-Phe
G-C 1601 Cys-Ser
ORF 2 T-C 285 No change
a Does not include the 9-nt differences from MHV-A59.
b Resulting from the deletion in viral amino acids 445 to 546.
c Resulting from a 3-nt deletion in the S gene sequence.
TABLE 2. Fixation rates of synonymous and nonsynonymous
substitutions for MHV-H2 genes
Viral gene(s)
No. of substitutions/site/yra
Synonymous Nonsynonymous
S/HE 6.75 3 1024 4.72 3 1023
M, N, 5AB, 4, 2 2.923 1023 8.36 3 1024
HE 2.70 3 1023 8.13 3 1023
S 0 3.59 3 1023
N 3.29 3 1023 0
M 4.67 3 1023 2.43 3 1023
5AB 2.70 3 1023 0
4 0 4.40 3 1023
2 2.17 3 1023 0
a Does not include alterations resulting from recombination and deletion.
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findings may reflect evolutionary patterns detected in the
MHV-H2 genome and suggest that the increased heterogene-
ity noted in the HE and S genes in the group II coronaviruses
was partially a consequence of interspecies transfer and adap-
tation to new host species. Importantly, the S and HE glyco-
protein genes of MHV-H2 contain less sequence variation
than that noted among different MHV strains in nature (31, 32,
48, 66). These findings suggest that a relatively few amino acid
alterations are needed to alter species specificity in coronavi-
ruses.
Beyond the generalized interpretation that mutations in the
MHV-H2 HE and S glycoprotein have expanded host range
specificity, no predictions can be made concerning the impor-
tance of individual mutations in this process. Certainly muta-
tions likely function in the establishment and maintenance of
MHV persistence in BHK cells or alter virus fusion, virulence,
or cell cytopathic effects in vitro. For example, a position 717
Arg-Gln change within the S1-S2 putative host protease cleav-
age site likely evolved as a consequence of persistence and
functions to decrease the rate of MHV-H2-induced fusion.
Similar mutations have been detected during persistent MHV
infection in murine cell lines (25). The MHV-H variants
should provide a means to identify virus residues that bind with
cellular receptor proteins and permit the identification of host
receptor protein residues that bind virus to initiate a produc-
tive infection in different species.
Evolutionary mechanisms of virus interspecies spread.
While the neutral or nearly neutral allele theories have suc-
cessfully accounted for many of the evolutionary phenomena
observed at the molecular level (24, 27, 45), a number of
findings have suggested that natural selection may also shape
the genetic structure of populations (20, 21). In support of
neutral theory, sequence analyses of many RNA and DNA
viruses have demonstrated that the accumulation of synony-
mous substitutions is about three- to fivefold higher than the
rate for nonsynonymous substitutions and also revealed that
many viral evolutionary clocks appear somewhat constant (24).
In contrast, eastern equine encephalitis virus has displayed
little genetic change over the past 50 years despite a prediction
of high mutation frequency (61). In addition, several reports
have demonstrated the accumulation of nonsynonymous sub-
stitutions during RNA virus or retrovirus evolution (8, 11).
Episodic selection theory proposes that molecular evolution
may be limited by the rate of change in the environment, with
one or more loci evolving by natural selection, genetic drift,
and mutation in response to these changing conditions. Influ-
enza A viruses have probably evolved by positive Darwinian
selection in response to host immune selection because hem-
agglutinins evolved more rapidly than nonstructural genes and
fixed proportionately more nonsynonymous mutations in anti-
genic sites in survivors than in nonsurvivors (17). Molecular
evolution in the P gene of vesicular stomatitis virus correlates
with a south-to-north geographic migration and is more con-
sistent with episodic evolution and positive Darwinian selec-
tion (44).
The extraordinarily high mutation rates seen in the
MHV-H2 S and HE glycoprotein genes (Table 2) are compa-
rable with rates observed in HIV and influenza virus except
that the majority of MHV-H2 mutations result in nonsynony-
mous changes. Although other mechanisms may also account
for the emergence of new viral diseases in nature, our findings
are most consistent with Gillespie’s episodic selection theory
since nonsynonymous mutations predominate and lineage ef-
fects could not account for the evolutionary pulse detected in
these genes (14, 20, 21). In contrast to neutral theory, our
findings also suggest that natural selection may actually in-
crease the evolution rates in functionally more important ge-
netic domains such as receptor binding residues, thereby per-
mitting more rapid viral adaptation, entry, and survival within
alternative hosts. While neutral theory could explain the evo-
lutionary changes seen in those MHV genes which did not
function in entry, positive Darwinian natural selection in the S
and HE glycoprotein genes was probably the principal force
driving the adaptation of MHV-H2 to hamster cell lines. Un-
fortunately, theories explaining evolutionary change and poly-
morphism by natural selection are not as well developed as
neutral theory because of the inherent difficulties in modeling
ecosystems and identifying the targets of selection at the mo-
lecular level (20, 21). More model systems are needed to de-
termine whether neutral evolution is an important evolution-
ary phenomena or represents, as suggested by some naturalists,
little more than evolutionary noise (34).
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